Leo Pharma to collaborate with US biotech company

Leo Pharma has found a new ally in biotech company X-Chem, entering into a discovery research agreement to develop new anti-inflammatory drugs.

Photo: Leo Pharma/ PR

X-Chem's platform for discovering new treatments is becoming popular – and this hasn't gone unnoticed by Leo Pharma, the latest company to show an interest in the biotech firm.

The two companies have now entered an agreement which aims to develop new drug candidates for Leo Pharma, though how many canditates the deal entails remains to be seen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs